Effects of VSL#3 on Metabolic, Endocrine, Lipidomic and Inflammatory Parameters of Pediatric Patients With BMI>90°

NCT01650025 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DIETARY_SUPPLEMENT: VSL#3 active probiotic
OTHER: VSL#3 placebo

Sponsor

Bambino Gesù Hospital and Research Institute